96 results
Page 3 of 5
8-K
EX-99.1
xr1osvp79dq7l
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
PRE 14A
fo61s fw264
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.2
x9pwcwiluk16z bbs
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.1
lb2xfvlmdv eu6k9x
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
S-8
EX-99.1
fcp8jt vl
31 Oct 22
Registration of securities for employees
4:07pm
8-K
EX-99.1
qi0equ3r
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
t5t mof8flwy
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.1
emwkyfz9onf i4
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.2
po0f1al
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
3k8j5n
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
424B5
hpzhry0m48 ljvg
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
bnkvjb
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
EX-99.1
3582ysuoj2da 9xb
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.2
tpuziamfn kvuv0tvrw
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
S-3
EX-4.4
cnrsi2e
1 Jun 22
Shelf registration
4:06pm
S-3
39mek a2ub3jjalsu98c
1 Jun 22
Shelf registration
4:06pm
S-3
EX-4.3
fnudq7q
1 Jun 22
Shelf registration
4:06pm